Abstract
β-Carboline moieties are important structural subunits which occur as components of many biologically interesting molecules for antitumor activity. The field of computer aided drug design and discovery (CADD) is a rapidly growing area that has seen many successes in the last few years. Through molecular docking, the binding mode and affinity of the protein-inhibitor complex formed is estimated which in turn helps in the discovery of new drug “Leads”. The anticancer potential of β-Carboline analogues was proven by various targeted mechanisms. In this review, we summarise the binding mode and interactions of β-Carboline derivatives towards the various anticancer targets which advantages the discovery of this scaffold into antitumor therapy.
Authors
Gomathi Priya Jeyapal, Rajendiran Krishnasamy, MJN Chandrasekar, & Jubie Selvaraj. (2023). In-silico binding approaches of β-carboline derivatives towards the possible antitumor targets. International Journal of Research in Pharmaceutical Sciences, 8(4), 734–740. Retrieved from https://ijrps.com/home/article/view/4645
Copyright (c) 2017 International Journal of Research in Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.